Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Volker Morath und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich 81675, Germany. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Akademie Ved Cesk?? Republiky, National Institute for Cancer Research (Programme EXCELES).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich 81675, Germany.
- Lehrstuhl für Biologische Chemie, School of Life Sciences, Technical University of Munich, Freising 85354, Germany.
- Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck 6020, Austria.
- Laboratory of Structural Biology, Institute of Biotechnology, Czech Academy of Sciences, Vestec 252 50, Czech Republic.
ORCID-Profile: Cyril Barinka, Clemens Decristoforo, Arne Skerra
Förderung
- Deutsche Forschungsgemeinschaft
- Akademie Ved Cesk?? Republiky
- National Institute for Cancer Research (Programme EXCELES)
Zitieren
APA
Morath, V., Brandt, C., Deuschle, F. C., Mendler, C. T., Blechert, B., Summer, D., Barinka, C., Decristoforo, C., Weber, W. A., Schwaiger, M., & Skerra, A. (2023). Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01066
Vancouver
Morath V, Brandt C, Deuschle FC, Mendler CT, Blechert B, Summer D, et al. Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01066
BibTeX
@article{Morath2023,
author = {Morath, Volker and Brandt, Corinna and Deuschle, Friedrich-Christian and Mendler, Claudia T and Blechert, Birgit and Summer, Dominik and Barinka, Cyril and Decristoforo, Clemens and Weber, Wolfgang A and Schwaiger, Markus and Skerra, Arne},
title = {Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01066}
}
EUVIMED